Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 21.96M | 29.95M | 43.09M | 39.24M | 29.19M |
Gross Profit | 5.19M | 4.73M | 20.24M | 18.43M | 7.99M |
EBITDA | -14.61M | -13.03M | 3.35M | 6.23M | -5.67M |
Net Income | -14.36M | -19.58M | 2.37M | 12.81M | -6.16M |
Balance Sheet | |||||
Total Assets | 40.98M | 48.88M | 69.21M | 64.92M | 48.90M |
Cash, Cash Equivalents and Short-Term Investments | 4.14M | 10.45M | 15.67M | 21.30M | 13.99M |
Total Debt | 4.41M | 2.93M | 3.70M | 4.17M | 1.79M |
Total Liabilities | 15.33M | 9.11M | 9.65M | 9.23M | 7.47M |
Stockholders Equity | 25.65M | 39.77M | 59.56M | 55.69M | 41.44M |
Cash Flow | |||||
Free Cash Flow | -8.32M | -5.16M | -988.11K | 5.99M | -286.79K |
Operating Cash Flow | -7.37M | -3.88M | 572.55K | 6.47M | 249.19K |
Investing Cash Flow | -1.04M | -1.28M | -1.56M | -733.47K | -535.98K |
Financing Cash Flow | 2.30M | -451.81K | 720.50K | 1.09M | 1.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $3.72B | 30.35 | 6.82% | 1.35% | -1.63% | -72.22% | |
73 Outperform | $195.52M | 22.32 | 15.81% | ― | 25.43% | 33.93% | |
71 Outperform | $295.61M | 24.27 | 3.52% | 7.25% | -0.65% | -51.59% | |
66 Neutral | $178.37M | ― | -2.83% | 17.42% | -4.32% | -144.96% | |
61 Neutral | $17.96B | 13.14 | -5.36% | 3.00% | 1.25% | -13.95% | |
45 Neutral | $2.40M | ― | -47.86% | ― | -33.51% | 36.29% | |
40 Underperform | $16.26M | ― | 89.94% | ― | -7.08% | -162.35% |
On June 24, 2025, Charles & Colvard entered into a Convertible Secured Note Purchase Agreement with Ethara Capital LLC, resulting in a $2.0 million investment issued in two tranches, with the final closing on July 21, 2025. Additionally, the company announced changes to its board of directors, including the resignation of Ollin Sykes and the appointment of Ruten Bhanderi and James Tu, with Mr. Tu becoming the new Chairman. These changes are part of the company’s strategic alignment with Ethara Capital’s interests, potentially impacting its governance and operational strategies.
On June 24, 2025, Charles & Colvard entered into a Convertible Secured Note Purchase Agreement with Ethara Capital LLC for $2.0 million, structured in two tranches. This agreement grants Ethara Capital the right to appoint directors and observers to Charles & Colvard’s board, while the company secures the note with its assets. The deal, subject to shareholder approval, allows for conversion into common stock and includes waivers of severance benefits by the company’s CEO and CFO, indicating a strategic move to strengthen its financial position and governance.